Skip to content
Clinical Trials
Our Network
Our Story
Clinical Trials
Our Network
Our Story
OnCore Login
Clinical Trials
Current Trials
Publications
Our Network
Clinical Trial Working Groups
Sponsor-Investigators
Fostering an Environment of Mentorship
Member Sites
Partners in Research
About
Our Story
Our Team
Annual Reports
Services
Biorepository & Correlative Services
Rapid Accrual
Efficient Timelines for Activation
Regulatory Compliance
Accurate & Relevant Data
News & Events
HCRN Calendar
Oncology Meetings
Make a Difference
Donate Now
Fundraising Events
Advocacy Organizations
Honor Your Hero
Careers
Contact
OnCore Login
network member
Winship Cancer Institute of Emory University
1365 C Clifton Road NE, Suite C3012, Atlanta, GA 30322
About Network Member
Seeing over 14,000 patients a year,
Winship Cancer Institute of Emory University
is Georgia’s only National Cancer Institute-designated cancer center and serves as the coordinating center for cancer research, education and care throughout Emory University.
Website
:
Winship Cancer Institute of Emory University
https://winshipcancer.emory.edu/index.html
Kim Nguyen
404-778-5680
Enrollment Closed
HCRN-GU19-385
Phase II Trial of Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer (PLANE-PC)
Ulka Vaishampayan
Cancer areas:
Prostate
City of Hope
Froedtert & the Medical College of Wisconsin
Knight Cancer Institute at Oregon Health & Science University
University of Michigan Rogel Cancer Center
Winship Cancer Institute of Emory University
Learn More
See clinicaltrials.gov
Currently Enrolling
HCRN-GU22-587
Advanced Renal Cell Cancer Combination ImmunoThErapy Clinical Trial (ARCITECT)
Cancer areas:
Kidney
Beth Israel Deaconess Medical Center
Columbia University Irving Medical Center
Dana-Farber Cancer Institute
Georgetown Lombardi Comprehensive Cancer Center
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
John Theurer Cancer Center at Hackensack Meridian Health
Moores Cancer Center at UC San Diego Health
Penn Medicine Abramson Cancer Center
The Ohio State University
UT Southwestern Harold C. Simmons Comprehensive Cancer Center
Weill Cornell Medicine
Winship Cancer Institute of Emory University
Yale Cancer Center
Learn More
See clinicaltrials.gov
Enrollment Closed
HCRN-GU16-260
Phase II study of front line therapy with nivolumab and salvage nivolumab + ipilimumab in patients with advanced renal cell carcinoma
Michael B. Atkins
Cancer areas:
Kidney
Beth Israel Deaconess Medical Center
Cleveland Clinic Cancer Center
Columbia University Irving Medical Center
Fox Chase Cancer Center
Georgetown Lombardi Comprehensive Cancer Center
Penn Medicine Abramson Cancer Center
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
University of Illinois Cancer Center
UT Southwestern Harold C. Simmons Comprehensive Cancer Center
Winship Cancer Institute of Emory University
Yale Cancer Center
Learn More
See clinicaltrials.gov
Current Trials
Our Network
Our Story
X
